Always listen to what your provider says
Weight-loss figure reflects average results from the manufacturer's (Novo Nordisk) clinical study of Wegovy used with lifestyle changes
18,19 Although heavy metal toxicities due to lead, mercury, and cadmium are generally considered rare in mainstream medicine, less well-recognized is that chronic accumulation that may not achieve classical acute toxicity thresholds may nevertheless contribute to adverse health effects
Retatrutide produced clinically meaningful reductions in HbA1c across the dose range alongside body-weight loss of about 17% at the top dose, with a safety profile in line with GLP-1 and dual GIP/GLP-1 agonists [2]
It is available in both once-weekly injections and daily oral formats
For simplicity, this Insight uses the term GLP-1 drugs to refer to both semaglutides and tirzepatides